Price is syncing
Reported smart-money activity is still available below.
1 month
+2.5%
price return
Year to date
+1.1%
price return
Recent earnings
1/4
quarters beat
Big funds
8
hold this stock
News tone
Bullish
19 articles, 7 days
Filed positions and reported activity tied to this stock.
8 funds hold a position and insiders have been net selling.
Real smart money
Insiders
Recent coverage and its overall tone.
News
Coverage leans bullish
8 bullish · 7 neutral · 4 bearish
Tone of tracked coverage
Rhythm Pharmaceuticals (RYTM) Q3 2025 Earnings Report - Results, Call & Slides
Leans bearishJul 24Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
NeutralJul 22Kuehn Law Encourages Investors of Rhythm Pharmaceuticals, Inc. to Contact Law Firm
BearishJul 21Kuehn Law Encourages Investors of Rhythm Pharmaceuticals, Inc. to Contact Law Firm
BearishJul 21RYTM stock trades around recent range as Rhythm Pharmaceuticals highlights setmelanotide growth
BullishJul 21Rhythm Pharmaceuticals schedules live Q2 results webcast Aug. 4
NeutralJul 21Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
NeutralJul 21Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
NeutralJul 21Q1 2026 13F
$120.0M
position
AlphaYou
